CAS: 15026-17-2; 4-(Tert-Butoxy)-4-Oxobutanoic Acid

该化合物是来自氨酸和丁醇的酯类,这种化合物一般是无色的黄色液体,其特征是新鲜的黄色液体,其特点是有水果味,在乙醇和乙醚等有机溶剂中溶解,但由于其缺水异丁基组,在水中溶解性有限;乙丁基乙烷组的存在加强了其稳定性,并与其他氨酸酯相比,改变了其再活性.单异丁基氨通常用作溶剂,增塑剂或有机合成的中间体,其化学结构允许在生产聚合物和食品工业中作为调味剂的潜在应用.此外,它具有低毒性,适合各种工业用途.与许多酯一样,它可能出现水解,在某些条件下恢复其母酸和酒精.

结构式图片

相似化合物

1070-34-4 3878-55-5 59854-12-5

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号15026-16-1 1-O-benzyl 4-O-... | CAS号14734-25-9 甲基琥珀酸叔丁酯 | CAS号108-30-5 丁二酸酐 | CAS号75-65-0 叔丁醇 | CAS号5292-43-3 溴乙酸叔丁酯 | CAS号110-15-6 琥珀酸; 丁二酸 | CAS号59524-02-6 N-叔丁氧羰基-L-丝氨酸 | CAS号926-26-1 丁二酸二叔丁酯 | CAS号1207973-75-8 acetic acid ter... | CAS号64916-53-6 bromoacetic aci... | CAS号432037-43-9 叔丁基氯甲基琥珀酸酯 | CAS号59854-12-5 4-羟基丁酸叔丁酯 | CAS号1663-39-4 丙烯酸叔丁酯 | CAS号51534-77-1 4-氧代丁酸叔丁酯 | CAS号110-15-6 琥珀酸; 丁二酸 | CAS号115-11-7 2-甲基丙烯

合成工艺路线路线简述

    N-叔丁氧羰基-L-丝氨酸 反应生成单叔丁基琥珀酸酯
    参考文献:Radiolabeled Proteins For Diagnostic Or Therapeutic Use
    标题:Radiolabeled Proteins For Diagnostic Or Therapeutic Use
    摘要:具有特定结构的螯合化合物对于放射性标记靶向分子(如抗体)非常有用.可切割的连接剂将放射性核素金属螯合物连接到抗体上.放射性标记的抗体具有改善的生物分布特性,包括减少在肠道和肾脏内的定位.

    海关参考信息

    专利信息


    专利号:US-2024092821-A1
    优先权日:2020-03-31
    标题:Synthesis of oligonucleotides and related compounds
    发明人:ZHONG MINGHONG; JIN YI; GALA DINESH; PRHAVC MARIJA
    权利人:JANSSEN BIOPHARMA INC
    摘要:Methods of synthesizing oligonucleotides via new intermediates on a cleavable support having an azidomethyl moiety are disclosed. The method comprises multiple reaction cycles, each of which comprises sequential coupling a nucleoside or oligonucleotide subunit on a cleavable support having an azidomethyl moiety and a nucleoside phosphoramidite or an oligonucleotide phosphoramidite, capping, oxidation/thiolation and deblocking; followed by orthogonal cleavage of the azidomethyl support while keeping all other protecting groups intact. The method can be used in combination with a support moiety for either solid phase or liquid phase oligo synthesis. The soluble support facilitates homogeneous reactions and efficient separations by simple precipitation. The methods also provide novel intermediates useful in the synthesis of oligonucleotide conjugates.

    专利号:US-11738092-B2
    优先权日:2019-12-04
    标题:Methods and compositions for synthesis of therapeutic nanoparticles
    发明人:WYENT EMILY A; BLUMENFELD CARL M; LAMM ROBERT J
    权利人:DANTARI INC
    摘要:Improved methods and reactants for the chemical synthesis of therapeutic nanoparticles are provided. The nanoparticles comprise a polymeric core, to which is attached one or more homing molecules and one or more therapeutic agents. Improvements in speed, yield and purity are attained using the methods disclosed herein.

    专利号:US-2013012706-A1
    优先权日:2010-03-01
    标 题 :Methods and Intermediates for the Synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines
    发明人:HUMMERSONE MARC GEOFFERY; COUSIN DAVID
    权利人:PHARMINOX LTD; HUMMERSONE MARC GEOFFERY; COUSIN DAVID
    摘要:The present invention provides a compound of general formula (II), or a salt or solvate thereof: n n n n n n n n n n n n wherein n A is independently -A 1 , -A 2 , -A 3 , -A 4 , -A 5 , -A 6 , or -A 7 , wherein:n -A 1 is independently C 5-12 heteroaryl, and is optionally substituted; -A 2 is independently thioamido or substituted thioamido; -A 3 is independently imidamido, substituted imidamido, N-hydroxyimidamido, or substituted N-hydroxyimidamido; -A 4 is independently hydroxamic acid or hydroxamate; -A 5 is independently carboxamide or substituted carboxamide; -A 6 is independently aliphatic C 2-6 alkenyl, and is optionally substituted; and -A 7 is independently carboxy or C 1-4 alkyl-carboxylate;n nand its use in the synthesis of temozolomide and analogues thereof.

    专利号:US-9574189-B2
    优先权日:2005-12-01
    标题:Enzymatic encoding methods for efficient synthesis of large libraries
    发明人:FRANCH THOMAS; LUNDORF MIKKEL DYBRO; JACOBSEN SØREN NYBOE; OLSEN EVA KAMPMANN; ANDERSEN ANNE LEE; HOLTMANN ANETTE; HANSEN ANDERS HOLM; SØRENSEN ANDERS MALLING; GOLDBECH ANNE; DE LEON DAEN; KALDOR DITTE KIEVSMOSE; SLØK FRANK ABILDGAARD; HUSEMOEN GITTE NYSTRUP; DOLBERG JOHANNES; Jensen Kim Birkebæ; PEDERSEN LENE; NØRREGAARD-MADSEN MADS; GODSKESEN MICHAEL ANDERS; GLAD SANNE SCHRØDER; NEVE SØREN; THISTED THOMAS; KRONBORG TINE TITILOLA AKINLEMINU; SAMS CHRISTIAN KLARNER; FELDING JAKOB; FRESKGÃ…RD PER-OLA; GOULIAEV ALEX HAAHR; PEDERSEN HENRIK
    权利人:FRANCH THOMAS; LUNDORF MIKKEL DYBRO; JACOBSEN SØREN NYBOE; OLSEN EVA KAMPMANN; ANDERSEN ANNE LEE; HOLTMANN ANETTE; HANSEN ANDERS HOLM; SØRENSEN ANDERS MALLING; GOLDBECH ANNE; DE LEON DAEN; KALDOR DITTE KIEVSMOSE; SLØK FRANK ABILDGAARD; HUSEMOEN GITTE NYSTRUP; DOLBERG JOHANNES; Jensen Kim Birkebæ; PEDERSEN LENE; NØRREGAARD-MADSEN MADS; GODSKESEN MICHAEL ANDERS; GLAD SANNE SCHRØDER; NEVE SØREN; THISTED THOMAS; KRONBORG TINE TITILOLA AKINLEMINU; SAMS CHRISTIAN KLARNER; FELDING JAKOB; FRESKGÃ…RD PER-OLA; GOULIAEV ALEX HAAHR; PEDERSEN HENRIK; NUEVOLUTION AS
    摘要:Disclosed is a method for obtaining a bifunctional complex comprising a molecule linked to a single stranded identifier oligonucleotide, wherein a nascent bifunctional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is a) reacted at the chemical reaction site with one or more reactants, and b) reacted enzymatically at the priming site with one or more tag(s) identifying the reactant(s).

    专利号:US-2021087191-A1
    优先权日:2020-12-04
    标 题 :SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-a]ISOQUINOLIN-2-OL COMPOUNDS, THEIR SYNTHESIS, AND USE THEREOF
    发明人:MILLER DAVE ALAN; ELLENBERGER DANIEL J; GUNIC ESMIR; GIRARDET JEAN-LUC; SPANGENBERG ANGELA
    权利人:DISPERSOL TECHNOLOGIES LLC
    摘要:The invention relates to substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol compounds, their synthesis, pharmaceutical compositions containing them, and methods of using them in the treatment of disorders benefiting from inhibition of vesicular monoamine transporter 2 (VMAT2).

    专利号:US-2023355800-A1
    优先权日:2019-12-04
    标 题 :Methods and compositions for synthesis of therapeutic nanoparticles
    上海常丰生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chainpharm.com
    企业联系电话:021-61727342👤
    📞上海常丰生物医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-61727342
    手机:13611721451
    传真:021-33275302
    邮箱:sales@chainpharm.com
    通信地址: 上海金山区金瓯路188号
    邮编: 201512
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海金山区金瓯路188号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏贵仁医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guirenchem.com
    企业联系电话:0519-83489086;13601507568👤
    📞江苏贵仁医药有限公司 ⚠️参考联系方式
    联系人:任经理qq:2402623097
    电话:0519-83489086;13601507568
    手机:13601507568
    传真:qq:2402623097
    邮箱:guiren_medicine@163.com
    通信地址: 江苏省常州市芮城县风陵渡开发区振兴北街北侧
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Ying Li, Et Al. One-Step And One-Pot-Two-Step Radiosynthesis Of Cyclo-Rgd-(18)F-Aryltrifluoroborate Conjugates For Functional Imaging. Am J Nucl Med Mol Imaging. 2013;3(1):44-56.

    合成参考文献


    参考文献:10.1055/s-0041-1737041
    摘要:Hydrocarboxylation of Activated Olefins by Photoinduced Thiol Catalysis. Synfacts. 2021 Oct 19;17(11):1261. doi: 10.1055/s-0041-1737041.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知